1Department of Orthopaedics, All India Institute of Medical Sciences, Bathinda (AIIMS Bathinda), Bathinda, India
2Department of Orthopaedics, All India Institute of Medical Sciences, Jodhpur (AIIMS Jodhpur), Jodhpur, India
© 2025 The Korean Society of Traumatology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Author contributions
Conceptualization: NB, AE; Data curation NB, GG, AE; Formal analysis: GG, SB, NG; Investigation, Methodology: NB; Project administration: NB, NG; Visualization: AR; Resources: AR; Software: AR; Writing–original draft: NB; Writing–review & editing: all authors. All authors read and approved the final manuscript.
Conflicts of interest
The authors have no conflicts of interest to declare.
Funding
The authors received no financial support for this study.
Data availability
Data analyzed in this study are available from the corresponding author upon reasonable request.
Characteristic | No. of patients (%)a) |
---|---|
Age (yr) | |
Mean±SD | 38.6±9.9 |
Range | 23–55 |
Sex | |
Male | 22 (81.5) |
Female | 5 (18.5) |
Time from injury to revision surgery (mo) | |
Mean±SD | 8.9±2.7 |
Range | 5–15 |
AO/OTA classification | |
33C1.3 | 1 (3.7) |
33C2.1 | 4 (14.8) |
33C2.2 | 5 (18.5) |
33C2.3 | 7 (25.9) |
33C3.1 | 3 (11.1) |
33C3.2 | 4 (14.8) |
33C3.3 | 3 (11.1) |
Varus deformity (°) | |
Mean±SD | 11.9±5.0 |
Range | 2–25 |
Media | 12 |
Flexion deformity (°) | 19 (70.4) |
Mean±SD | 4.6±2.9 |
Range | 2–10 |
Median | 5 |
Extension deformity (°) | 8 (29.6) |
Mean±SD | 3.8±2.1 |
Range | 2–8 |
Median | 3 |
Limb pain (VAS score) | |
Mean±SD | 5.8±1.4 |
Range | 4–8 |
Median | 6 |
LKS score | |
Mean±SD | 29.2±11.5 |
Range | 12–67 |
Median | 30 |
Study | No. of patients | Inclusion of infected nonunions | Type of implant used in revision surgery | Type of revision surgery performed | Union rate following revision surgery (%) | Complication | Mean duration of union |
---|---|---|---|---|---|---|---|
Lee et al. [28] (2024) | 15 | No | Lateral and medial supplementation using T-plate | ORIF with dual plate | 93 | Infection (n=1, 6.6%) | 29 wk |
Saxena et al. [26] (2023) | 10 | No | Nail-plate construct | Nail augmented with plate and bone grafting | 100 | None | 10.3 mo |
Lotzien et al. [27] (2023) | 20 | No | Large fragment titanium medial supplementary plate | Debridement of the nonunion site, bone grafting and medial augmentation | 90 | Nonunion (n=2, 10%) | 8.16 mo |
Infection (n=1, 5%) | |||||||
Mukhopadhaya et al. [20] (2022) | 31 | No | Anatomical lateral locking plate | Debridement of nonunion, decortication of the fracture ends | 100 | None | 6.42 mo |
Kanakeshwar et al. [25] (2017) | 22 | No | Distal femoral locking plate | Cortical peg allograft struts on the medial side | 100 | Superficial infection (n=1, 4.5%) | 6.2 mo |
Ebraheim et al. [22] (2016) | 14 | No | Lateral locking plate | ORIF with iliac crest autograft (n=5) | 57 | Iliac crest donor side morbidity (n=2, 14.3%) | 19 wk |
rhBMP-2 (n=12) | Infection (n=2, 14.3%) | ||||||
Crushed cancellous bone allograft (n=3) | Implant failure (n=2, 14.3%) | ||||||
Medial supplementation (n=2) | Malunion with valgus deformity (n=1, 7.1%) | ||||||
Persistent nonunion (n=6, 42.8%) | |||||||
Vaishya et al. [30] (2011) | 8 | No | Megaprosthesis | Knee prosthesis | 100a) | Prolonged surgical site discharge with marginal necrosis (n=3, 37.5%) | NA |
Monroy et al. [23] (2014) | 22 | No | Revision of the same implant (lateral plate, n=19; intramedullary nail, n=3) | Placement of autogenous iliac crest bone grafts, iliac crest aspirates, cancellous chip allografts, or BMP | 100 | Additional surgery (n=3, 13.6%) | 7 mo |
Gardner et al. [21] (2008) | 31 | No | Laterally placed fixed-angle device | Bone graft augmentation (71% received iliac crest bone graft and 29% received DBM) | 97 | Nonunion (n=1, 3.2%) | 16.1 wk |
Haidukewych et al. [29] (2005) | 17 | No | Total knee arthroplasty | Modular, hinged distal femoral arthroplasty | 83b) | Revision of arthroplasty (n=3, 17.6%) | NA |
Intraoperative complications (n=5, 29.4%) | |||||||
Ali and Saleh [24] (2002) | 15 | Yes | External fixator | External fixator application | 93 | Nonunion (n=1, 6.7%) | 10.4 mo |
ORIF, open reduction and internal fixation; rhBMP-2, recombinant human bone morphogenetic protein 2; NA, not applicable; BMP, bone morphogenetic protein; DBM, demineralized bone matrix.
a)Revision-free survival of implant until the last follow-up at 4 years.
b)Revision-free 5-year survival of the prosthesis.
Characteristic | No. of patients (%) |
---|---|
Age (yr) | |
Mean±SD | 38.6±9.9 |
Range | 23–55 |
Sex | |
Male | 22 (81.5) |
Female | 5 (18.5) |
Time from injury to revision surgery (mo) | |
Mean±SD | 8.9±2.7 |
Range | 5–15 |
AO/OTA classification | |
33C1.3 | 1 (3.7) |
33C2.1 | 4 (14.8) |
33C2.2 | 5 (18.5) |
33C2.3 | 7 (25.9) |
33C3.1 | 3 (11.1) |
33C3.2 | 4 (14.8) |
33C3.3 | 3 (11.1) |
Varus deformity (°) | |
Mean±SD | 11.9±5.0 |
Range | 2–25 |
Media | 12 |
Flexion deformity (°) | 19 (70.4) |
Mean±SD | 4.6±2.9 |
Range | 2–10 |
Median | 5 |
Extension deformity (°) | 8 (29.6) |
Mean±SD | 3.8±2.1 |
Range | 2–8 |
Median | 3 |
Limb pain (VAS score) | |
Mean±SD | 5.8±1.4 |
Range | 4–8 |
Median | 6 |
LKS score | |
Mean±SD | 29.2±11.5 |
Range | 12–67 |
Median | 30 |
Patient no. | Nature of initial injury | Presence/extent of callus after index surgery | Infection after index surgery | Plate breakage after index surgery | Plate bending after index surgery | Time from injury to revision surgery (mo) | Type of revision surgery or first-stage surgery | Type of re-revision surgery or second-stage surgery |
---|---|---|---|---|---|---|---|---|
1 | Close | No | No | Yes | Yes | 10 | IR + DP + autograft + allograft | - |
2 | Close | No | No | Yes | Yes | 11 | IR + DP + autograft + allograft | - |
3 | Close | No | No | Yes | Yes | 9 | IR + DP + autograft + allograft | - |
4 | Close | No | No | Yes | Yes | 7 | IR + DP + autograft + allograft | - |
5 | Open | No | Yes | Yes | Yes | 8 | IR, debridement, DP, antibiotic cement spacer | Cement spacer removal + autograft + allograft |
6 | Close | Scant | No | No | Yes | 6 | IR + DP + autograft + allograft | - |
7 | Close | No | No | No | No | 5 | IR + DP + autograft + allograft | - |
8 | Close | Moderate | No | No | Yes | 7 | MP + autograft + allograft | - |
9 | Close | No | No | No | No | 6 | IR + DP + autograft + allograft | Autograft grafting |
10 | Close | No | No | No | Yes | 8 | IR + DP + autograft + allograft | - |
11 | Close | No | No | No | No | 9 | IR + DP + autograft + allograft | - |
12 | Close | Scant | No | No | Yes | 13 | IR + DP + autograft + allograft | Autograft grafting |
13 | Close | No | No | Yes | Yes | 15 | IR + DP + autograft + allograft | - |
14 | Close | No | No | Yes | Yes | 12 | IR + DP + autograft + allograft | - |
15 | Close | Moderate | No | No | Yes | 13 | IR + DP + autograft + allograft | - |
16 | Open | No | Yes | No | Yes | 15 | IR, debridement, DP, antibiotic cement spacer | Cement spacer removal + autograft + allograft |
17 | Close | Scant | No | No | Yes | 8 | IR + DP + autograft + allograft | - |
18 | Close | No | No | No | Yes | 9 | IR + DP + autograft + allograft | - |
19 | Close | No | No | No | Yes | 7 | IR + DP + autograft + allograft | - |
20 | Open | Scant | No | No | Yes | 6 | IR + DP + autograft + allograft | Autograft grafting |
21 | Close | No | No | Yes | Yes | 8 | IR + DP + autograft + allograft | - |
22 | Open | No | Yes | No | Yes | 9 | IR, debridement, DP, antibiotic cement spacer | Cement spacer removal + autograft + allograft |
23 | Close | Moderate | No | No | Yes | 11 | IR + DP + autograft + allograft | - |
24 | Close | No | No | Yes | Yes | 10 | IR + DP + autograft + allograft | - |
25 | Close | No | No | No | Yes | 5 | IR + DP + autograft + allograft | - |
26 | Close | Scant | No | No | Yes | 7 | MP + autograft + allograft | Autograft grafting |
27 | Close | No | No | No | Yes | 8 | MP + autograft + allograft | - |
Variable | Range | Mean±SD | Median | P-value |
---|---|---|---|---|
Varus deformity (°) | <0.001 | |||
Before revision surgery | 2–25 | 11.9±5.0 | 12 | |
After revision surgery | 3–8 | 5.0±2.4 | 5 | |
Flexion deformity (°) (n=19) | 0.397 | |||
Before revision surgery | 2–10 | 4.6±2.9 | 5 | |
After revision surgery | 2–8 | 4.2±1.7 | 2 | |
Extension deformity (°) (n=8) | 0.171 | |||
Before revision surgery | 2–8 | 3.8±2.1 | 3 | |
After revision surgery | 2–8 | 4.3±2.1 | 3 | |
Limb pain (VAS score) | <0.001 | |||
Before revision surgery | 4–8 | 5.8±1.4 | 6 | |
After revision surgery | 1–6 | 3.0±1.3 | 3 | |
LKS score | <0.001 | |||
Before revision surgery | 12–67 | 29.2±11.5 | 30 | |
After revision surgery | 66–90 | 79.0±6.2 | 80 |
Study | No. of patients | Inclusion of infected nonunions | Type of implant used in revision surgery | Type of revision surgery performed | Union rate following revision surgery (%) | Complication | Mean duration of union |
---|---|---|---|---|---|---|---|
Lee et al. [28] (2024) | 15 | No | Lateral and medial supplementation using T-plate | ORIF with dual plate | 93 | Infection (n=1, 6.6%) | 29 wk |
Saxena et al. [26] (2023) | 10 | No | Nail-plate construct | Nail augmented with plate and bone grafting | 100 | None | 10.3 mo |
Lotzien et al. [27] (2023) | 20 | No | Large fragment titanium medial supplementary plate | Debridement of the nonunion site, bone grafting and medial augmentation | 90 | Nonunion (n=2, 10%) | 8.16 mo |
Infection (n=1, 5%) | |||||||
Mukhopadhaya et al. [20] (2022) | 31 | No | Anatomical lateral locking plate | Debridement of nonunion, decortication of the fracture ends | 100 | None | 6.42 mo |
Kanakeshwar et al. [25] (2017) | 22 | No | Distal femoral locking plate | Cortical peg allograft struts on the medial side | 100 | Superficial infection (n=1, 4.5%) | 6.2 mo |
Ebraheim et al. [22] (2016) | 14 | No | Lateral locking plate | ORIF with iliac crest autograft (n=5) | 57 | Iliac crest donor side morbidity (n=2, 14.3%) | 19 wk |
rhBMP-2 (n=12) | Infection (n=2, 14.3%) | ||||||
Crushed cancellous bone allograft (n=3) | Implant failure (n=2, 14.3%) | ||||||
Medial supplementation (n=2) | Malunion with valgus deformity (n=1, 7.1%) | ||||||
Persistent nonunion (n=6, 42.8%) | |||||||
Vaishya et al. [30] (2011) | 8 | No | Megaprosthesis | Knee prosthesis | 100 |
Prolonged surgical site discharge with marginal necrosis (n=3, 37.5%) | NA |
Monroy et al. [23] (2014) | 22 | No | Revision of the same implant (lateral plate, n=19; intramedullary nail, n=3) | Placement of autogenous iliac crest bone grafts, iliac crest aspirates, cancellous chip allografts, or BMP | 100 | Additional surgery (n=3, 13.6%) | 7 mo |
Gardner et al. [21] (2008) | 31 | No | Laterally placed fixed-angle device | Bone graft augmentation (71% received iliac crest bone graft and 29% received DBM) | 97 | Nonunion (n=1, 3.2%) | 16.1 wk |
Haidukewych et al. [29] (2005) | 17 | No | Total knee arthroplasty | Modular, hinged distal femoral arthroplasty | 83 |
Revision of arthroplasty (n=3, 17.6%) | NA |
Intraoperative complications (n=5, 29.4%) | |||||||
Ali and Saleh [24] (2002) | 15 | Yes | External fixator | External fixator application | 93 | Nonunion (n=1, 6.7%) | 10.4 mo |
SD, standard deviation; VAS, visual analog scale; LKS, Tegner Lysholm Knee Scoring Scale. Unless otherwise indicated.
IR, implant removal; DP, dual plates; MP, medial plate.
SD, standard deviation; VAS, visual analog scale; LKS, Tegner Lysholm Knee Scoring Scale.
ORIF, open reduction and internal fixation; rhBMP-2, recombinant human bone morphogenetic protein 2; NA, not applicable; BMP, bone morphogenetic protein; DBM, demineralized bone matrix. Revision-free survival of implant until the last follow-up at 4 years. Revision-free 5-year survival of the prosthesis.